$69 postpage LB

CSL Signs Agreement to Manufacture & Supply COVID-19 Vaccine | ASX Market Update

  • September 08, 2020 04:37 PM AEST
  • Team Kalkine

PointsBet Holdings Limited (ASX: PBH) announced the commencement of the institutional component of its 1 for 6.5 accelerated pro-rata renounceable entitlement offer to raise A$153.2 million by issuing each new share at A$6.50. The Retail Entitlement Offer component of the Entitlement Offer is anticipated to open on 11 September 2020 and close on 22 September 2020. Retail rights trading shall be available from 9 September 2020 till 15 September 2020.

Gold MTF non-AMP

Viva Energy Group Limited (ASX: VEA) provided a trading update amid easing of restrictions in Victoria on 6 September and the impact of coronavirus. Below are some of the highlights: Retail business continues to be resilient even after on-going restrictions in Victoria and sales is recovering in other states and territories. Commercial business excluding Aviation in Victoria also stays relatively unaltered by the present restrictions.

ASX 200 listed biotech major, CSL Limited (ASX:CSL) signed two agreements to manufacture and supply COVID-19 vaccines V451 and AZD1222, subject to clinical trials of both proving successful. Heads of agreement (HoA) with the Government of Australia to supply nearly 51 million doses of the University of Queensland’s COVID-19 vaccine candidate (V451). Another HoA with AstraZeneca to manufacture the COVID-19 vaccine candidate of the Oxford University (AZD1222).

 

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK